Letters to the Editor Open Access

Ischemic Stroke in the COVID-19 Patient

Ivan Lozada-Martinez1, Daniela M. Torres-Llinás1, Luis R. Moscote-Salazar1, Sabrina Rahman2, AHM Ataullah3, Nazmul Huda Ridoy4 and Moshiur Rahman5
  • 1 University of Cartagena, Colombia
  • 2 Independent University-Bangladesh, Bangladesh
  • 3 Sher-E-Bangla Medical College Hospital, Bangladesh
  • 4 Jahurul Islam Medical College, Bangladesh
  • 5 Holy Family Red Crescent Medical College, Bangladesh
Neuroscience International
Volume 12 No. 1, 2021, 1-3

DOI: https://doi.org/10.3844/amjnsp.2021.1.3

Submitted On: 4 January 2021 Published On: 25 March 2021

How to Cite: Lozada-Martinez, I., Torres-Llinás, D. M., Moscote-Salazar, L. R., Rahman, S., Ataullah, A., Ridoy, N. H. & Rahman, M. (2021). Ischemic Stroke in the COVID-19 Patient. Neuroscience International, 12(1), 1-3. https://doi.org/10.3844/amjnsp.2021.1.3


Currently, there are many questions around the real impact of COVID-19 at an organic level and the resolution of these is one of the main objectives of the scientific societies and public health institutions around the world, to establish the most effective and safe management protocol in the approach of this disease (Qureshi et al., 2020). Systematic reviews and meta-analyses mention that the common presentation of this entity is based on a syndromic picture, composed of fever, cough, asthenia, adynamia, myalgia and dyspnea (Rodriguez-Morales et al., 2020; Fu et al., 2020). However, other studies report that the initial presentation may debut with isolated pneumonia, sudden respiratory failure, myocardial injury, renal failure, encephalitis, or stroke (Zhao et al., 2020). Ischemic stroke is a condition of severe brain injury that leads to high rates of morbidity, mortality and disability, in addition to high economic costs in terms of diagnostic, therapeutic and rehabilitation intervention (Tan et al., 2020).

  • 0 Citations